• Patient Care
• Education
• Research
• Community
• Referring Physicians
• Find a Physician
• Departments & Centers
• About Us

• Libraries
• Alumni
• Giving
• Home

URMC » Quality » Ratings » Heart Attack

Email this page

• Choose Us
• Commitment to Quality
• Quality Measures
  • Heart Attack
    • Overview
    • Aspirin on admission
    • Beta blocker on admission
    • Aspirin at discharge
    • Beta blocker at discharge
    • ACEI or ARB at discharge for patients with left ventricular systolic dysfunction
    • Smoking cessation
    • Availability of PTCA
    • Inpatient mortality for heart attacks
    • Length of stay for heart attack patients
    • Lipid-lowering therapy at discharge
    • Low-density lipoprotein (LDL) cholesterol assessment
  • Percutaneous Transluminal Coronary Angioplasty (PTCA)
  • Coronary Bypass Surgery (CABG)
  • Heart Failure
  • Pneumonia
  • Robotic Prostatectomy
  • Stroke
• Glossary of Terms

 

Beta Blocker at Discharge

At Strong Memorial Hospital, from Q2 2005 to Q2 2006, 98.3% of heart attack survivors received a prescription for a beta blocker (group of medications that block the stress hormone adrenaline) at discharge, unless otherwise contraindicated.

Source: United States Department of Health & Human Services

For heart attack survivors, starting beta blockers at or before discharge has been shown to reduce death and disability (American Heart Journal, December 2004: 148 (6); 944-50).